Dominique Missiakas

Dominique Missiakas

Auto-generated profile, based on publicly available information

Dominique Missiakas

Department of Microbiology, Howard Taylor Ricketts Laboratory, The University of Chicago, Lemont, Illinois, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MBMonica L. Burts
Monica L. Burts
WWWade A. Williams
Wade A. Williams
KDKristin DeBord
Kristin DeBord
DMDominique M. Missiakas
Dominique M. Missiakas
Mycobacterium tuberculosissecretes ESAT-6, a virulence factor that triggers cell-mediated immune responses and IFN-γ production during tuberculosis. ESAT-6 is transported across the bacterial envelope by a specialized secretion system with a FSD (FtsK-SpoIIIEdomain) membrane protein. Although the presence of ESAT-6-like genes has been identified in the genomes of other microbes, the possibility that they may encode general virulence functions has hitherto not been addressed. Herein we show that the human pathogenStaphylococcus aureussecretes EsxA and EsxB, ESAT-6-like proteins, across the bacterial envelope. StaphylococcalesxAandesxBare clustered with six other genes and some of these are required for synthesis or secretion of EsxA and EsxB. Mutants that failed to secrete EsxA and EsxB displayed defects in the pathogenesis ofS. aureusmurine abscesses, suggesting that this specialized secretion system may be a general strategy of human bacterial pathogenesis.

1 May 2011 in Trends in Microbiology
Verified
Journal Article
Closed access
ACAlice G. Cheng
Alice G. Cheng
ADAndrea C. DeDent
Andrea C. DeDent
OSOlaf Schneewind
Olaf Schneewind
DMDominique Missiakas
Dominique Missiakas

12 September 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg
WWWade A. Williams
Wade A. Williams
DMDominique Missiakas
Dominique Missiakas
Toll-like receptors and other immune-signaling pathways play important roles as sensors of bacterial pattern molecules, such as peptidoglycan, lipoprotein, or teichoic acid, triggering innate host immune responses that prevent infection. Immune recognition of multiple bacterial products has been viewed as a safeguard against stealth infections; however, this hypothesis has never been tested forStaphylococcus aureus, a frequent human pathogen. By generating mutations that block the diacylglycerol modification of lipoprotein precursors, we show here thatS. aureusvariants lacking lipoproteins escape immune recognition and cause lethal infections with disseminated abscess formation, failing to elicit an adequate host response. Thus, lipoproteins appear to play distinct, nonredundant roles in pathogen recognition and host innate defense mechanisms againstS. aureusinfections.

19 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JKJennifer Klunk
Jennifer Klunk
TVTauras P. Vilgalys
Tauras P. Vilgalys
CDChristian E. Demeure
Christian E. Demeure
XCXiaoheng Cheng
Xiaoheng Cheng
MSMari Shiratori
Mari Shiratori
LBLuis B. Barreiro
Luis B. Barreiro

20 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LELamiaa El-Shennawy
Lamiaa El-Shennawy
AHAndrew D. Hoffmann
Andrew D. Hoffmann
NDNurmaa Khund Dashzeveg
Nurmaa Khund Dashzeveg
KMKathleen M. McAndrews
Kathleen M. McAndrews
PMPaul J. Mehl
Paul J. Mehl
HLHuiping Liu
Huiping Liu
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the pandemic of the coronavirus induced disease 2019 (COVID-19) with evolving variants of concern. It remains urgent to identify novel approaches against broad strains of SARS-CoV-2, which infect host cells via the entry receptor angiotensin-converting enzyme 2 (ACE2). Herein, we report an increase in circulating extracellular vesicles (EVs) that express ACE2 (evACE2) in plasma of COVID-19 patients, which levels are associated with severe pathogenesis. Importantly, evACE2 isolated from human plasma or cells neutralizes SARS-CoV-2 infection by competing with cellular ACE2. Compared to vesicle-free recombinant human ACE2 (rhACE2), evACE2 shows a 135-fold higher potency in blocking the binding of the viral spike protein RBD, and a 60- to 80-fold higher efficacy in preventing infections by both pseudotyped and authentic SARS-CoV-2. Consistently, evACE2 protects the hACE2 transgenic mice from SARS-CoV-2-induced lung injury and mortality. Furthermore, evACE2 inhibits the infection of SARS-CoV-2 variants (α, β, and δ) with equal or higher potency than for the wildtype strain, supporting a broad-spectrum antiviral mechanism of evACE2 for therapeutic development to block the infection of existing and future coronaviruses that use the ACE2 receptor.

15 March 2014 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
OSOlaf Schneewind
Olaf Schneewind
DMDominique Missiakas
Dominique Missiakas
Lipoteichoic acids (LTA) are polymers of alternating units of a polyhydroxy alkane, including glycerol and ribitol, and phosphoric acid, joined to form phosphodiester units that are found in the envelope of Gram-positive bacteria. Here we review four different types of LTA that can be distinguished on the basis of their chemical structure and describe recent advances in the biosynthesis pathway for type I LTA, d -alanylated polyglycerol-phosphate linked to di-glucosyl-diacylglycerol. The physiological functions of type I LTA are discussed in the context of inhibitors that block their synthesis and of mutants with discrete synthesis defects. Research on LTA structure and function represents a large frontier that has been investigated in only few Gram-positive bacteria.